Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11123808rdf:typepubmed:Citationlld:pubmed
pubmed-article:11123808lifeskim:mentionsumls-concept:C0855279lld:lifeskim
pubmed-article:11123808lifeskim:mentionsumls-concept:C0205473lld:lifeskim
pubmed-article:11123808lifeskim:mentionsumls-concept:C1523987lld:lifeskim
pubmed-article:11123808pubmed:issue4lld:pubmed
pubmed-article:11123808pubmed:dateCreated2001-1-29lld:pubmed
pubmed-article:11123808pubmed:abstractTextThe crossmatch has evolved from including a wide range of techniques through a test purely to eliminate ABO incompatibility (immediate spin) to computer crossmatching in which no serological testing is carried out and validation ensures the correct ABO/RhD type blood is issued. The crossmatch was always considered to be the most important feature of the compatibility test and in particular the antiglobulin phase; however, there are potential risks associated with serological and computer crossmatching including technical and procedural errors. The use of immediate spin and computer crossmatch change the emphasis for safety of the compatibility test from the crossmatch to the antibody screen. UK guidelines have now been published describing the features necessary for the introduction of computer crossmatching. Computer crossmatching is used by many institutions in various countries. It is considered safe practice and brings benefits to the laboratory and the patient. Compatibility testing is only one element of the blood transfusion procedure; the others are equally as important and include correct patient identification at the time of collection of the blood sample and at the administration of the blood transfusion.lld:pubmed
pubmed-article:11123808pubmed:languageenglld:pubmed
pubmed-article:11123808pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11123808pubmed:citationSubsetIMlld:pubmed
pubmed-article:11123808pubmed:statusMEDLINElld:pubmed
pubmed-article:11123808pubmed:monthDeclld:pubmed
pubmed-article:11123808pubmed:issn0958-7578lld:pubmed
pubmed-article:11123808pubmed:authorpubmed-author:VoakDDlld:pubmed
pubmed-article:11123808pubmed:authorpubmed-author:ChapmanJ FJFlld:pubmed
pubmed-article:11123808pubmed:authorpubmed-author:MilkinsCClld:pubmed
pubmed-article:11123808pubmed:issnTypePrintlld:pubmed
pubmed-article:11123808pubmed:volume10lld:pubmed
pubmed-article:11123808pubmed:ownerNLMlld:pubmed
pubmed-article:11123808pubmed:authorsCompleteYlld:pubmed
pubmed-article:11123808pubmed:pagination251-6lld:pubmed
pubmed-article:11123808pubmed:dateRevised2008-7-31lld:pubmed
pubmed-article:11123808pubmed:meshHeadingpubmed-meshheading:11123808...lld:pubmed
pubmed-article:11123808pubmed:meshHeadingpubmed-meshheading:11123808...lld:pubmed
pubmed-article:11123808pubmed:meshHeadingpubmed-meshheading:11123808...lld:pubmed
pubmed-article:11123808pubmed:meshHeadingpubmed-meshheading:11123808...lld:pubmed
pubmed-article:11123808pubmed:meshHeadingpubmed-meshheading:11123808...lld:pubmed
pubmed-article:11123808pubmed:meshHeadingpubmed-meshheading:11123808...lld:pubmed
pubmed-article:11123808pubmed:meshHeadingpubmed-meshheading:11123808...lld:pubmed
pubmed-article:11123808pubmed:year2000lld:pubmed
pubmed-article:11123808pubmed:articleTitleThe computer crossmatch: a safe alternative to the serological crossmatch.lld:pubmed
pubmed-article:11123808pubmed:affiliationBarts and the London NHS Trust, London, UK. j.f.chapman@mds.qmw.ac.uklld:pubmed
pubmed-article:11123808pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:11123808pubmed:publicationTypeReviewlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11123808lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11123808lld:pubmed